
    
      Duration of the study for each subject will be between 33 to 77 days, including screening up
      to 28 days, 5 days of treatment Period 1, washout period of 7-21 days, 9 days of treatment
      Period 2, and follow-up period of 10-14 days after last dose of the Investigational Medicinal
      Product (IMP) in Period 2.
    
  